Effect of Pemafibrate on Cerebrovascular Atherosclerosis in Patients with Stroke and Hypertriglyceridemia.

J Atheroscler Thromb · 2025 · PMC12140850 · PMID 39617480

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

borderline significantP =0.053so close (0.05 < p ≤ 0.1)

1.52 mm at 2 years; P =0.009) and borderline significant for the right side (1.32 mm at baseline vs. 1.28 mm at 2 years; P =0.053).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.